Annual Shareholders Equity
$105.53 M
-$101.66 M-49.07%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual stockholders equity is currently $105.53 million, with the most recent change of -$101.66 million (-49.07%) on 31 December 2023. During the last 3 years, it has risen by +$17.88 million (+20.40%). TNXP annual shareholders equity is now -51.75% below its all-time high of $218.72 million, reached on 31 December 2021.TNXP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$74.21 M
+$32.11 M+76.26%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly stockholders equity is currently $74.21 million, with the most recent change of +$32.11 million (+76.26%) on 30 September 2024. Over the past year, it has dropped by -$46.62 million (-38.58%). TNXP quarterly shareholders equity is now -71.43% below its all-time high of $259.78 million, reached on 30 June 2022.TNXP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -49.1% | -38.6% |
3 y3 years | +20.4% | -63.3% |
5 y5 years | +345.9% | +653.0% |
TNXP Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -51.8% | +20.4% | -71.4% | +76.3% |
5 y | 5 years | -51.8% | +1020.6% | -71.4% | +688.0% |
alltime | all time | -51.8% | +4400.3% | -71.4% | +3124.2% |
Tonix Pharmaceuticals Holding Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $74.21 M(+76.3%) |
June 2024 | - | $42.10 M(-61.1%) |
Mar 2024 | - | $108.14 M(+2.5%) |
Dec 2023 | $105.53 M(-49.1%) | $105.53 M(-12.7%) |
Sept 2023 | - | $120.83 M(-14.0%) |
June 2023 | - | $140.46 M(-15.1%) |
Mar 2023 | - | $165.43 M(-20.2%) |
Dec 2022 | $207.18 M(-5.3%) | $207.18 M(-9.5%) |
Sept 2022 | - | $228.92 M(-11.9%) |
June 2022 | - | $259.78 M(+24.9%) |
Mar 2022 | - | $207.96 M(-4.9%) |
Dec 2021 | $218.72 M(+149.5%) | $218.72 M(+8.2%) |
Sept 2021 | - | $202.22 M(+12.0%) |
June 2021 | - | $180.49 M(+2.0%) |
Mar 2021 | - | $176.92 M(+101.8%) |
Dec 2020 | $87.65 M(+830.7%) | $87.65 M(+40.1%) |
Sept 2020 | - | $62.57 M(+16.8%) |
June 2020 | - | $53.57 M(+71.4%) |
Mar 2020 | - | $31.25 M(+231.8%) |
Dec 2019 | $9.42 M(-60.2%) | $9.42 M(-4.4%) |
Sept 2019 | - | $9.86 M(-23.1%) |
June 2019 | - | $12.82 M(-28.0%) |
Mar 2019 | - | $17.81 M(-24.7%) |
Dec 2018 | $23.66 M(-3.9%) | $23.66 M(+72.6%) |
Sept 2018 | - | $13.71 M(-13.5%) |
June 2018 | - | $15.84 M(-14.9%) |
Mar 2018 | - | $18.61 M(-24.4%) |
Dec 2017 | $24.62 M(-2.9%) | $24.62 M(-14.2%) |
Sept 2017 | - | $28.68 M(-15.6%) |
June 2017 | - | $33.97 M(+54.6%) |
Mar 2017 | - | $21.98 M(-13.4%) |
Dec 2016 | $25.36 M | $25.36 M(-6.4%) |
Sept 2016 | - | $27.11 M(-9.8%) |
Date | Annual | Quarterly |
---|---|---|
June 2016 | - | $30.03 M(+9.9%) |
Mar 2016 | - | $27.34 M(-32.1%) |
Dec 2015 | $40.26 M(+11.6%) | $40.26 M(-23.5%) |
Sept 2015 | - | $52.65 M(+13.9%) |
June 2015 | - | $46.24 M(-18.7%) |
Mar 2015 | - | $56.89 M(+57.6%) |
Dec 2014 | $36.09 M(+454.2%) | $36.09 M(-17.6%) |
Sept 2014 | - | $43.78 M(+2.6%) |
June 2014 | - | $42.66 M(-11.0%) |
Mar 2014 | - | $47.92 M(+635.9%) |
Dec 2013 | $6.51 M(+579.0%) | $6.51 M(+19.8%) |
Sept 2013 | - | $5.44 M(-376.9%) |
June 2013 | - | -$1.96 M(+206.9%) |
Mar 2013 | - | -$639.70 K(-166.7%) |
Dec 2012 | $959.00 K(-139.1%) | $959.00 K(-242.2%) |
Sept 2012 | - | -$674.30 K(-194.3%) |
June 2012 | - | $714.90 K(-288.7%) |
Mar 2012 | - | -$378.90 K(-84.6%) |
Dec 2011 | -$2.45 M(+1298.2%) | -$2.45 M(>+9900.0%) |
Sept 2011 | - | -$15.00 K(+18.1%) |
June 2011 | - | -$12.70 K(+13.4%) |
Mar 2011 | - | -$11.20 K(-93.6%) |
Dec 2010 | -$175.50 K(-1562.5%) | -$175.50 K(<-9900.0%) |
Sept 2010 | - | $100.00(-97.4%) |
June 2010 | - | $3800.00(-38.7%) |
Mar 2010 | - | $6200.00(-48.3%) |
Dec 2009 | $12.00 K(-72.0%) | $12.00 K(-22.6%) |
Sept 2009 | - | $15.50 K(-14.4%) |
June 2009 | - | $18.10 K(-43.4%) |
Mar 2009 | - | $32.00 K(-25.4%) |
Dec 2008 | $42.90 K | $42.90 K(-1200.0%) |
Sept 2008 | - | -$3900.00(+1200.0%) |
June 2008 | - | -$300.00(-106.0%) |
Mar 2008 | - | $5000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual stockholders equity?
- What is the all time high annual shareholders equity for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual shareholders equity year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly shareholders equity year-on-year change?
What is Tonix Pharmaceuticals Holding annual stockholders equity?
The current annual shareholders equity of TNXP is $105.53 M
What is the all time high annual shareholders equity for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual stockholders equity is $218.72 M
What is Tonix Pharmaceuticals Holding annual shareholders equity year-on-year change?
Over the past year, TNXP annual stockholders equity has changed by -$101.66 M (-49.07%)
What is Tonix Pharmaceuticals Holding quarterly stockholders equity?
The current quarterly shareholders equity of TNXP is $74.21 M
What is the all time high quarterly shareholders equity for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly stockholders equity is $259.78 M
What is Tonix Pharmaceuticals Holding quarterly shareholders equity year-on-year change?
Over the past year, TNXP quarterly stockholders equity has changed by -$46.62 M (-38.58%)